ArticleInflammopharmacology2026
Synergistic wound healing mechanisms of Heliotropium curassavicum extracts via redox modulation, inflammation suppression, and tissue remodeling: linking phytochemical diversity to antioxidant and anti-inflammatory effects.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of Multi-Bioactive Driven Composite Plant Extracts and Functional Study in Mice and Piglets.Antioxidants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study assessed the wound-healing potential of Heliotropium curassavicum via a comparative metabolite profiling of its ethanol (HC-EtOH), ethyl acetate (HC-EtOAc), and n-butanol (HC-BuOH) extracts, alongside in vivo assessment. UHPLC-ESI-MS/MS analysis annotated 86 metabolites, including 13 pyrrolizidine alkaloids (4 of which, viz. uplandicine, uluganine, curassavine, and curassavine N-oxide are newly reported in the genus), 12 phenylpropanoids, and 8 fatty acid amides. Topical application of the extracts accelerated wound closure in a dose-dependent manner, with HC-BuOH exhibiting the strongest activity. HC-BuOH (200 mg/kg) achieved near-complete closure by day 14 and improved healing by 39% compared with Intrasite Gel. This was accompanied by significant modulation of oxidative and inflammatory markers, including a 66% reduction in MDA, a 220% increase in GSH, a 94% reduction in TNF-α, and restoration of PGE-2 toward normal levels (p < 0.05). Histopathology confirmed complete re-epithelialization, organized collagen deposition, and localized Ki-67 expression in HC-BuOH–treated wounds. Multivariate data and interaction analyses, supported by PLSR model demonstrated that the superior wound-healing activity of HC-BuOH is attributed for synergistic interactions among pyrrolizidine alkaloids, phenylpropanoids, and fatty acyl amides. These findings highlight H. curassavicum, particularly the HC-BuOH fraction, as a promising natural wound-healing agent. These effects are likely attributed to plant richness, in pyrrolizidine alkaloids, phenylpropanoids, and fatty acyl amides, highlighting its potential as a natural wound healing agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.